DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+35.64%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$291M
AUM Growth
+$291M
(+9.6%)
Cap. Flow
-$34.7M
Cap. Flow
% of AUM
-11.9%
Top 10 Holdings %
Top 10 Hldgs %
53.99%
Holding
96
New
7
Increased
8
Reduced
27
Closed
15
Top Buys
| 1 |
ProQR Therapeutics
PRQR
|
$8.45M |
| 2 |
AFMD
Affimed
AFMD
|
$3.11M |
| 3 |
OTIC
Otonomy, Inc.
OTIC
|
$1.8M |
| 4 |
Neuronetics
STIM
|
$1.3M |
| 5 |
NextCure
NXTC
|
$1.13M |
Top Sells
| 1 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$12M |
| 2 |
Ascendis Pharma
ASND
|
$4.5M |
| 3 |
Apellis Pharmaceuticals
APLS
|
$3.95M |
| 4 |
Ardelyx
ARDX
|
$2.86M |
| 5 |
argenx
ARGX
|
$2.55M |
Sector Composition
| 1 | Healthcare | 91.92% |
